Deal Title Date Announced Stage Type Primary Therapeutic Area Primary Indication Primary Tech Article
Diligent Health purchasing Diplomat’s business unit 10.16.19 10 Not Applicable Business Unit Purchase Not Applicable Not Applicable Not Applicable Link
Hsiri development and commercialization deal with Shionogi 10.11.19 01 Platform / Discovery Dev and Commercial Infectious Mycrobacterium Small Molecule Link
Aclaris commercialization deal with EPI Health 10.10.19 06 Approved Sales / Co-Promotion Dermatologic Rosaceo Small Molecule Link
ONE HUNDRED contract service deal with Gobel Group 10.07.19 10 Not Applicable Contract Service Not Applicable Not Applicable Not Applicable Link
Context Therapeutics clinical trial collaboration with Wisconsin Oncology Network 10.07.19 04 Phase II University/Foundation Cancer Breast Cancer Small Molecule Link
CHOP development and commercialization deal with Tmunity 10.01.19 09 Not Disclosed Dev and Commercial License Cancer Cancer (General) Immunotherapy / Cell Therapy Link
OptiNose commercialization deal with Currax 9.26.19 06 Approved Sales / Co-Promotion Only Neurologic Migraine Small Molecule Link
NIH grant to Knoop 9.26.19 01 Platform / Discovery University / Foundation Other Pain Other Tech Link
Eisai co-promotion deal with Mylan 9.20.19 06 Approved Sales / Co-Promotion Only Cancer Cancer (General) Small Molecule Link
Context clinical trial agreement with Jefferson Health 9.19.19 04 Phase II R&D Only Cancer Endometrial cancer Formulation – Oral Link
NIH grant to Inovio Pharmaceuticals 9.17.19 02 Preclinical / IND University / Foundation Infectious Bacterial Infection Biologic (General) Link
Penn State Health purchasing ViewRay’s system 9.16.19 01 Platform / Discovery Platform, Product Purchase Cancer Cancer (General) Unknown Link
Context Therapeutics clinical trial agreement with SOLTI 9.16.19 04 Phase II University / Foundation Cancer Breast Cancer Other Tech Link
Oncora research partnership with Varian Medical 9.13.19 09 Not Disclosed R&D Only Cancer Cancer (General) Other Tech Link
Castle Creek acquiring Fibrocell 9.12.19 06 Approved Acquisition Dermatologic Genetic diseases Small Molecule Link
HIG Capital acquiring BioVectra 9.10.19 10 Not Applicable Acquisition Not Applicable Not Applicable Not Applicable Link
Phio Pharma research partnership with Carisma Therapeutics to develop immunotherapy 9.09.19 01 Platform / Discovery R&D Only Cancer Cancer (General) Immunotherapy / Cell Therapy Link
MDA grant to Thomas Jefferson University 9.05.19 09 Not Disclosed University / Foundation Neurologic Amyotrophic lateral sclerosis (ALS) Gene Therapy Link
IMV research partnership with the Wistar Institute 9.04.19 01 Platform / Discovery University / Foundation Cancer Non-Hodgkin’s lymphoma (NHL) Immunotherapy / Cell Therapy Link
Lannett contract service deal with Cediprof 8.27.19 06 Approved Contract Service Cancer Cancer (General) Unknown Link
Genomind contract service deal with NeuroFlow 8.19.19 09 Not Disclosed Contract Service Other Other Other Tech Link
Q-State research partnership 2bPrecise to develop clinical-genomic datasets 8.13.19 10 Not Applicable R&D Only Not Applicable Not Applicable Not Applicable Link
Mission clinical trial agreement with Onconova to evaluate rigosertib 8.12.19 01 Platform / Discovery R&D Only Cancer Cancer (General) Small Molecule Link
Penn research partnership with AC Immune for neurodegenerative diseases 8.12.19 01 Platform / Discovery University / Foundation Neurologic Amyotrophic lateral sclerosis (ALS) Protein Link
AstraZeneca license option deal with Aevi for MEDI2338 8.07.19 04 Phase II Option to license Inflaation Inflammatory disease Antibody Link
BioIVT acquiring Keystone Biologicals 8.06.19 10 Not Applicable Acquisition Not Applicable Not Applicable Diagnostic-Other Link
TerrAscend acquiring Ilera Healthcare 8.02.19 10 Not Applicable Acquisition Not Applicable Not Applicable Other Tech Link
Bigfoot Biomedical research partnership with Allegheny Health Network 8.01.19 07 Device – Any R&D Only Endocrine/Metabolic Diabetes Device (General) Link
Pfizer’s generics business Upjohn merged with Mylan in a Reverse Morris Trust transaction 7.29.19 06 Approved Acquisition Autoimmune Allergy Small Molecule Link
Helomics research partnership with UPMC for ovarian cancer 7.18.19 01 Platform / Discovery University / Foundation Cancer Ovarian Cancer Other Tech Link
Medial EarlySign research partnership with Geisinger to develop machine learning-based solutions 7.10.19 01 Platform / Discovery R&D Only Gastrointestinal Gastrointestinal Other Tech Link
Celsius research partnership with Janssen Biotech to identify response biomarkers for ulcerative colitis 7.09.19 01 Platform / Discovery R&D Only Gastrointestinal Colitis Sequencing Link
AmerisourceBergen contract service with OneOncology 7.08.19 10 Not Applicable Contract Service Cancer Cancer (General) Stem Cell Link
Versant Ventures formed Century Therapeutics 7.01.19 01 Platform / Discovery Company Formation Cancer Hematologic malignancies Stem Cell Link
Fujifilm development and commercialization deal Century Therapeutics for iPSC platform 7.01.19 01 Platform / Discovery Dev and Commercial License Cancer Cancer (General) Stem Cell Link
GD3 acquiring NexusPharma 6.18.19 09 Not Disclosed Acquisition Cancer Cancer (General) Other Tech Link
Tekni-Plex purchasing Amcor’s three manufacturing facility 6.17.19 10 Not Applicable Facility Purchase Not Applicable Not Applicable Not Applicable Link
Orchestra development and commercialization deal with Terumo for Virtue SEB 6.13.19 07 Device – Any Dev and Commercial Other Percutaneous coronary intervention (PCI) Device (General) Link
Genmab research partnership with Janssen with an option to license HexaBody-CD3 6.11.19 01 Platform / Discovery Option to License Cancer Multiple myeloma (MM) Antibody Link
DTRA grant to Inovio 6.10.19 07 Device-Any University/Foundation Unknown Not Applicable Device (General) Link
University of Pennsylvania research partnership with Amicus to develop gene therapy 5.29.19 01 Platform / Discovery University / Foundation Endocrine/Metabolic Metabolic (General) Gene Therapy Link
Ilera development and commercialization deal with Ethicann for CAN-001 5.22.19 09 Not Disclosed Dev and Commercial License Cancer Cancer (General) Other Tech Link
LifeScan commercialization deal with Sanvita for Continuous Glucose Monitoring (CGM) Devices 5.21.19 07 Device – Any Sales / Co-Promotion Only Endocrine / Metabolic Diabetes Device (General) Link
JPMorgan Chase acquiring InstaMed 5.17.19 10 Not Applicable Acquisition Not Applicable Not Applicable Not Applicable Link
Inovio research partnership with Qiagen to co-develop companion diagnostic 5.16.19 08 Diagnostic – Any R&D Only Cancer Cervical Dysplasia Diagnostic – Companion Link
Onconova development and commercialization deal with HanX for Rigosertib 5.13.19 05 Phase III Dev and Commerical Hematologic Myelodysplastic Syndrome (MDS) Small Molecule Link
Tmunity license deal with UCSF for TCR T cell therapy 5.01.19 02 Preclinical / IND University / Foundation Cancer Cancer (General) Immunotherapy / Cell Therapy Link
Sensus research partnership with the University of Pennsylvania for IORT system 4.24.19 01 Platform / Discovery University / Foundation Cancer Cancer (General) Other Tech Link
Prescient Medicine acquiring AutoGenomics 4.23.19 08 Diagnostic – Any Acquisition Other Other Diagnostic-Other Link
RxGenomix contract service deal with Coriell Life 4.23.19 10 Not Applicable Contract Service Not Applicable Not Applicable Other Tech Link
CareCentrix contract service deal with Turn-Key Health 4.23.19 10 Not Applicable Contract Service Other Pain Unknown Link
TB Alliance commercialization deal with Mylan for two regimens 4.18.19 09 Not Disclosed Sales / Co-Promotion Only Infectious Tuberculosis Small Molecule Link
Fibrocell development and commercialization deal with Castle for FCX-007 4.15.19 04 Phase II Dev and Commercial Dermatologic Genetic Diseases Gene Therapy Link
Gyroscope Acquiring Orbit 4.11.19 10 Device – Any Acquisition Ophthalmic Ophthalmic (General) Device (General) Link
URGO purchasing Realm’s technology 4.09.19 10 Not Applicable Platform, Product Purchase Other Wounds Other Tech Link
PhaseBio development and commercialization deal with ImmunoForge for PB1023 4.09.19 01 Platform / Discovery Dev and Commercial Cancer Unknown Not Applicable Link
Antengene research partnership with Baruch S. Blumberg Institute 4.08.19 08 Diagnostic – Any R&D Only Cancer Hepatitis B Virus Diagnostic – Other Link
Dr. Reddy’s commercialization deal with Encore for SERNIVO, TRIANEX and PROMISEB 4.02.19 06 Approved Sales / Co-Promotion Only Dermatologic Dermatologic (General) Formulation – Topical Link
Group K Diagnostics research partnership with Centers for Disease Control and Prevention 3.26.19 08 Diagnostic – Any University / Foundation Infectious Infectious (General) Diagnostic – Lab Based Assay Link
Titan Medical research partnership with Teleflex for robotic ligation technology 3.25.19 01 Platform / Discovery R&D Only Not Applicable Not Applicable Other Tech Link
Biofrontera acquiring Cutanea Life 3.25.19 09 Not Disclosed Acquisition Dermatologic Dermatologic (General) Small Molecule Link
Knopp Biosciences research partnership with an undisclosed consortium 3.20.19 04 Phase II R&D Only Pulmonary Asthma Small Molecule Link
NCCN grant to Taiho 3.14.19 04 Phase II University / Foundation Cancer Solid tumors Small Molecule Link
Geisinger research partnership with OBERD for data integration tools 3.12.19 01 Platform / Discovery University / Foundation Unknown Not Applicable Other Tech Link
NIH grant to Geisinger 3.04.19 09 Not Disclosed University / Foundation Cardiovascular Cardiovascular (General) Other Tech Link
NIAID grant to VenatoRx 2.28.19 09 Not Disclosed University / Foundation Infectious Gram-negative bacterial infection Other Tech Link
Roche acquiring Spark Therapeutics 2.23.19 06 Approved Acquisition Ophthalmic Genetic Diseases Gene Therapy Link
Winstar Institute development and commercialization deal with Cullinan for VK-2019 1.30.19 09 Not Disclosed Dev and Commercial Cancer General within the TA or an unspecified indications Unknown Link
Knopp research partnership with Cincinnati to develop dexpramipexole 1.16.19 04 Phase II University/Foundation Inflammation Asthma Small Molecule Link
Luminex development and commercialization deal with AllerGenis for diagnostic assay 1.16.19 08 Diagnostic – Any Dev and Commercial Other Allergy Diagostic-Lab Link
GOG research partnership with OncoSec 1.07.19 08 Diagnostic – Any GOG research partnership with OncoSec Cancer Cervical Cancer Gene Therapy Link
Integral research partnership with Daiichi for I-O therapeutics 1.07.19 01 Platform / Discovery R&D Only Cancer General within the TA or an unspecified indication Protein Link
Knopp Biosciences research partnership with Baylor College of Medicine 1.03.19 09 Not Disclosed University/Foundation Neurologic Epilepsy Unknown Link
Integral Molecular research partnership with Ono Pharmaceutical 1.03.19 09 Not Disclosed R&D Only Unknown Unknown Biologic (General) Link
NCI grant to the University of Pennsylvania 1.02.19 09 Not Disclosed University/Foundation Cancer Solid Tumors Immunotherapy / Cell Therapy Link
Windtree acquiring CVie 12.21.18 09 Not Disclosed Acquisition Cardiovascular General within the TA or an unspecified indication Unknown Link
Ligand purchasing Palvella’s royalty rights to PTX-022 12.17.18 04 Phase II Royalty Stream Purchase Dermatologic General within the TA or an unspecified indication Formulation – Topical Link
Cabaletta Bio license deal with the University of Pennsylvania for CAAR T Cell Technology 11.08.18 01 Platform / Discovery Dev and Commercial Autoimmune Pemphigus vulgaris (PV) Immunotherapy / Cell Therapy Link
Cabaletta Bio license deal with the University of Pennsylvania for CAAR T Cell Technology 11.08.18 01 Platform / Discovery Dev and Commercial Autoimmune Pemphigus vulgaris (PV) Immunotherapy / Cell Therapy Link
BioNTech license deal with the University of Pennsylvania to develop Vaccine for infectious diseases 11.05.18 01 Platform / Discovery University/Foundation Infectious General within the TA or an unspecified indication Vaccine Link
Yuhan development and commercialization deal with Janssen for Lazertinib 11.05.18 03 Phase I Dev and Commercial Pulmonary Non-small cell lung cancer (NSCLC) Small Molecule Link
NIH grant to Integral Molecular 11.01.18 10 Not Applicable University/Foundation Neurologic Alzheimer’s disease (AD) Proteomics Link
NIH grant to Integral Molecular 11.01.18 10 Not Applicable University/Foundation Neurologic Alzheimer’s disease (AD) Proteomics Link
KemPharm commercialization deal with KVK for APADAZ 10.30.18 06 Approved Sales / Co-Promotion Only Unknown Not Applicable Small Molecule Link
Gates Foundation grant to Inovio Pharmaceuticals 10.17.18 01 Platform / Discovery University/Foundation Not Applicable Not Applicable Device (General) Link
Allergan development and commercialization deal with Aclaris for RHOFADE 10.15.18 06 Approved Dev and Commercial Dermatologic Rosacea Formulation – Topical Link
Adynxx reverse merging with Alliqua 10.12.18 07 Device – Any Reverse Merger Unknown Not Applicable Device (General) Link
Adynxx reverse merging with Alliqua 10.12.18 07 Device – Any Reverse Merger Unknown Not Applicable Device (General) Link
Hemispherx clinical trial agreement with Roswell Park Cancer to evaluate Ampligen in combination with checkpoint inhibitors (CPIs) 10.10.18 09 Not Disclosed University/Foundation Cancer Melanoma RNA Link
University of Pennsylvania research partnership with Amicus to develop AAV gene therapies 10.08.18 01 Platform / Discovery University/Foundation Endocrine/Metabolic Pompe’s disease Gene Therapy Link
NIH commercialization deal with MTTI for Lutathera 10.08.18 06 Approved Sales / Co-Promotion Only Neurologic Neuroendocrine tumors Other Tech Link
Teleflex acquiring Essential Medical 10.04.18 07 Device – Any Acquisition Cardiovascular General within the TA or an unspecified indication Device (General) Link
NIA grant to Cognition Therapeutics to conduct Phase 2 SHINE study 10.02.18 04 Phase II University/Foundation Neurologic Alzheimer’s disease (AD) Small Molecule Link
Wistar Institute spinning off Virion Therapeutics 09.26.18 09 Not Disclosed Company Formation Infectious Viral Infection Vaccine Link
VenatoRx development and commercialization deal with Everest Medicines for cefepime/VNRX-5133 09.25.18 05 Phase III Dev and Commercial License Infectious Urinary tract infection Small Molecule Link
USFDA grant to Fibrocell 09.25.18 09 Not Disclosed University/Foundation Dermatologic General within the TA or an unspecified indication Gene Therapy Link
NIDA grant to MEBIAS 09.24.18 02 Preclinical / IND University/Foundation Pulmonary General within the TA or an unspecified indication Unknown Link
Clarus purchasing Galera’s royalty rights of GC4419 09.19.18 04 Phase II Royalty Stream Purchase Gastrointestinal General within the TA or an unspecified indication Unknown Link
Abzena development and commercialization deal with Tmunity for CAR-T engineered products 09.19.18 01 Platform / Discovery Dev and Commercial Cancer Solid tumors Biologic (General) Link
Integral Molecular research partnership with Merus to develop monoclonal antibodies 09.18.18 01 Platform / Discovery R&D Only Unknown Unknown Biologic (General) Link
TRIMEDX purchasing Aramark’s healthcare technologies business 09.17.18 10 Not Applicable Business Unit Purchase Unknown Unknown Unknown Link
Johnson & Johnson acquiring EIT 09.12.18 07 Device – Any Acquisition Musculoskeletal General within the TA or an unspecified indication Device (General) Link
Novo Nordisk research partnership with Ossianix with an option to license its VNAR antibodies 09.04.18 01 Platform / Discovery Option to License Endocrine / Metabolic Diabetes Biologic (General) Link
Imalogix contract service deal with Guerbet 08.13.18 01 Platform / Discovery Contract Service Unknown Not Applicable Other Tech Link
Context Therapeutics partnership with leading breast cancer investigators to evaluate Apristor 08.08.18 04 Phase II University / Foundation Cancer Breast Cancer Small Molecule Link
University of Pennsylvania research partnership with Aevitas Therapeutics to evaluate gene therapy technology 08.06.18 01 Platform / Discovery University / Foundation Unknown Not Applicable Gene Therapy Link
University of Pennsylvania development and commercialization deal with Neovasc for Tiara 08.03.18 07 Device – Any Dev and Commercial Cardiovascular General within the TA or an unspecified indication Device (General) Link
Andor granted Lannett rights to commercialize generic Methylphenidate Hydrochloride ER 08.03.18 10 Not Applicable Sales / Co-Promotion Only Unknown Unknown Small Molecule Link
Secant Group development and commercialization deal with Atvio to develop cell therapy 07.30.18 01 Platform / Discovery Dev and Commercial License Endocrine / Metabolic Diabetes Immunotherapy / Cell Therapy Link
360 Knee Systems development and commercialization deal with DePuy Synthes (Johnson & Johnson) for digital solutions for knee replacement 07.23.18 07 Device – Any Dev and Commercial License Musculoskeletal Bone Repair Device (General) Link
Isogenica development and commercialization deal with Aro Biotherapeutics 07.23.18 01 Platform / Discovery Dev and Commercial License Unknown Unknown Unknown Link
Botanix research partnership with University of Queensland to develop BTX 1801 07.19.18 09 Not Disclosed University / Foundation Dermatologic Bacterial Infection Other Tech Link
Janssen granted EUSA rights to commercialize SYLVANT 07.18.18 06 Approved Sales / Co-Promotion Only Hematologic General within the TA or an unspecified indication Biologic (General) Link
MedPharm development and commercialization deal with Virpax for MedSpray technology 06.21.18 01 Platform / Discovery Dev and Commercial License Other Pain Unknown Link
University of Pennsylvania research partnership with Ophthotech 06.07.18 02 Preclinical / IND University / Foundation Ophthalmic Retinitis Gene Therapy Link
LipoCure research partnership with Virpax 06.04.18 02 Preclinical / IND University / Foundation Ophthalmic Retinitis Gene Therapy Link
University of Pennsylvania research partnership with Ophthotech 06.07.18 02 Preclinical / IND University / Foundation Ophthalmic Retinitis Gene Therapy Link
LipoCure research partnership with Virpax 06.04.18 02 Preclinical / IND R&D Only Other Pain Formulation – Liposomal Link
DePuy purchasing J&J’s surgical impactor technology including ME1000 05.14.18 07 Device – Any Platform, Product Purchase Other Not Applicable Device (General) Link
Aeterna Zentaris development and commercialization deal with Strongbridge Biopharma 05.08.18 06 Approved Dev and Commercial License Endocrine / Metabolic Growth hormone deficiency Formulation – Oral Link
Regeneron research partnership with Inovio 05.08.18 03 Phase I R&D Only Neurologic Brain Cancer Antibody Link
Lannett purchasing Endo’s generics portfolio 05.07.18 06 Approved Business Unit Purchase Unknown Not Applicable Other Tech Link
Janssen Biotech acquiring Benevir Biopharm 05.03.18 02 Preclinical / IND Acquisition Cancer Not Applicable Immunotherapy / Cell Therapy Link
Link
Trevena development and commercialization deal with Jiangsu Nhwa Pharmaceutical 05.01.18 09 Not Disclosed Dev and Commercial License Other Pain Small Molecule Link
Jazz purchasing Spark Therapeutics’s Priority Review Voucher 04.30.18 10 Not Applicable Platform, Product Purchase Not Applicable Not Applicable Not Applicable Link
CEPI grant to Inovio Pharmaceuticals 04.11.18 02 Preclinical / IND University / Foundation Infectious General within the TA or an unspecified indication Vaccine Link
Morphotek granted Bliss rights to its Eribulin-Linker Payload to develop antibody drug conjugates (ADC) 04.09.18 01 Platform / Discovery Dev and Commercial License Cancer Not Applicable Antibody Link
Aclaris development and commercialization deal with Cipher 04.06.18 06 Approved Dev and Commercial License Dermatologic Not Applicable Formulation – Topical Link
Innate Biologics research partnership with Wistar 03.21.18 01 Platform / Discovery University / Foundation Inflammation Unknown Unknown Link
ImmunoRestoration license deal with University of Pennsylvania 03.14.18 01 Platform / Discovery University / Foundation Cancer Breast Cancer Vaccine Link
Hemispherx Biopharma research partnership with UNMC 03.14.18 09 Not Disclosed University / Foundation Cancer Pancreatic Cancer Vaccine Link
Windtree research partnership with Eleison 03.12.18 04 Phase II R&D Only Cancer Lung Cancer Immunotherapy Link
Aevi Genomic granted Kyowa Hakko an option to license the development and commercialization of its monoclonal antibody 03.07.18 02 Preclinical / IND Option to License Unknown Unknown Antibody Link
Onconova commercialization deal with Pint for Rigosertib in Latin America 03.05.18 05 Phase III Sales / Co-Promotion Only Cancer Myelodysplastic syndrome (MDS) Small Molecule Link
NIH grant to PhaseBio 02.27.18 03 Phase I University / Foundation Cardiovascular Hypertension Protein Link
Boston Therapeutics acquiring CureDM 02.19.18 04 Phase II Acquisition Endocrine / Metabolic Not Applicable Peptide Link
Spark Therapeutics development and commercialization deal with Novartis 01.24.18 05 Phase III Dev and Commercial License Ophthalmic General within the TA or an unspecified indication Gene Therapy Link
Torrent Pharma acquiring Bio-Pharm 01.18.18 10 Not Applicable Acquisition Not Applicable Not Applicable Not Applicable Link
Context Therapeutics purchasing Arno’s Apristor 01.16.18 04 Phase II Platform, Product Purchase Cancer Breast Cancer Small Molecule Link
Oncoceutics development and commercialization deal with Frontida BioPharm for ONC201 01.16.18 04 Phase II Dev and Commercial License Cancer General within the TA or an unspecified indication Small Molecule Link
Inovio research partnership with Parker Institute for Cancer Immunotherapy 01.09.18 03 Phase I University / Foundation Cancer Bladder Cancer Immunotherapy / Cell Therapy Link
J&J license deal with University of Pennsylvania 01.05.18 01 Platform / Discovery University / Foundation Neurologic Alzheimer’s disease (AD) Gene Therapy Link
Koch Institute for Integrative Cancer Research research partnership with Janssen 01.05.18 01 Platform / Discovery R&D Only Cancer Lung cancer Not Applicable Link
Mindera research partnership with Janssen 01.05.18 07 Device – Any R&D Only Inflammation Inflammatory disease Device (General) Link
WinterLight Labs research partnership with Janssen to use voice analysis in Alzheimer’s detection 01.05.18 01 Platform / Discovery R&D Only Neurologic Alzheimer’s disease (AD) Digital Health Link
Treventis development and commercialization deal with Servier 01.04.18 09 Not Disclosed Dev and Commercial License Neurologic Alzheimer’s disease (AD) Protein Link
DTRA grant to VenatoRx 01.04.18 10 Not Applicable University / Foundation Infectious Bacterial infection Not Applicable Link